Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O43525: Variant p.Gly310Val

Potassium voltage-gated channel subfamily KQT member 3
Gene: KCNQ3
Feedback?
Variant information Variant position: help 310 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Valine (V) at position 310 (G310V, p.Gly310Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In BFNS2; about 50% reduction of wild-type heteromeric current; ratio of 1:1; or 20%; ratio of 1:1:2. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 310 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 872 The length of the canonical sequence.
Location on the sequence: help DAQGEEMKEEFETYADALWW G LITLATIGYGDKTPKTWEGR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         DAQGEEMKEEFETYADALWWGLITLATIGYGDKTPKTWEGR

Mouse                         DAQGEEMKEEFETYADALWWGLITLATIGYGDKTPKTWEGR

Rat                           DAQGEEMKEEFETYADALWWGLITLATIGYGDKTPKTWEGR

Bovine                        DAQGEEMKEEFETYADALWWGLITLATIGYGDKTPKTWEGR
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 872 Potassium voltage-gated channel subfamily KQT member 3
Intramembrane 303 – 315 Pore-forming; Name=Segment H5
Mutagenesis 318 – 318 G -> S. >50% Reduction of wt heteromeric current; ratio of 1:1 and 1:1:2.



Literature citations
Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy.
Schroeder B.C.; Kubisch C.; Stein V.; Jentsch T.J.;
Nature 396:687-690(1998)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; CHARACTERIZATION OF VARIANT BFNS2 VAL-310; MUTAGENESIS OF GLY-318; FUNCTION; A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family.
Charlier C.; Singh N.A.; Ryan S.G.; Lewis T.B.; Reus B.E.; Leach R.J.; Leppert M.;
Nat. Genet. 18:53-55(1998)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 48-872 (ISOFORM 1); VARIANT BFNS2 VAL-310; KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.
Singh N.A.; Westenskow P.; Charlier C.; Pappas C.; Leslie J.; Dillon J.; Anderson V.E.; Sanguinetti M.C.; Leppert M.F.;
Brain 126:2726-2737(2003)
Cited for: VARIANTS BFNS2 GLY-305 AND VAL-310; CHARACTERIZATION OF VARIANT BFNS2 GLY-305; VARIANT SER-468; CHARACTERIZATION OF VARIANT SER-468; FUNCTION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.